Health Care · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · CIK 1840877 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $0.64Day −5.24%Mkt cap $49M1Y −57.7%Off 52W high −60.0%Vol (1Y) 109.3%
Daily closing price, split-adjusted to the current basis; 2.8y shown of 702 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest1.1% of sh out |
| Days to cover2.3d |
| 13F net flow (QoQ)+0.53% |
| Top-10 13F concentration97.2% |
| Next report (est.)2026-08-13 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$234,000 |
| Earnings (TTM)-$23.1M |
| Net margin−9857.3% |
| Sales growth 3Y0.6% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−2.7% |
| 1Y−57.7% |
| Since incept. (ann.)−50.9% |
Total return through 2026-07-29 · series begins 2023-10-02. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)109.3% |
| Ann. volatility (3Y)167.3% |
| Sharpe (1Y)−0.33 |
| Sharpe (3Y)0.19 |
| Max drawdown (1Y)−75.0% |
| Max drawdown (3Y)−96.1% |
| Beta (3Y vs SPY)3.88 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 7.7M | $5M | 9.95% | new |
| Bleichroeder LP | 6.3M | $4M | 8.13% | new |
| VANGUARD CAPITAL MANAGEMENT LLC | 881,672 | $586,312 | 1.15% | new |
| DSG Capital Advisors, LLC | 625,000 | $415,688 | 0.81% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 521,824 | $347,083 | 0.68% | +430.6% |
| VANGUARD FIDUCIARY TRUST CO | 294,721 | $195,989 | 0.38% | new |
| Focus Partners Wealth | 212,655 | $141,437 | 0.28% | +0.0% |
| Arcus Capital Partners, LLC | 187,573 | $124,755 | 0.24% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-11 | −$0.08 | — | $39,000 | −15.2% |
| 2025-12-31 | 2026-03-23 | — | — | $75,000 | +78.6% |
| 2025-09-30 | 2025-11-10 | −$0.35 | — | $42,000 | −25.0% |
| 2025-06-30 | 2025-07-31 | −$0.32 | — | $78,000 | +14.7% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-13 is ESTIMATED from filing cadence (median gap 94d) — not company-confirmed.
All Other Segments 100%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
